251 related articles for article (PubMed ID: 8930008)
1. Safety of mirtazapine: a review.
Montgomery SA
Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():37-45. PubMed ID: 8930008
[TBL] [Abstract][Full Text] [Related]
2. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.
Montgomery SA; Reimitz PE; Zivkov M
Int Clin Psychopharmacol; 1998 Mar; 13(2):63-73. PubMed ID: 9669186
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.
Kasper S
Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():25-35. PubMed ID: 8930007
[TBL] [Abstract][Full Text] [Related]
5. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
Fawcett J; Barkin RL
J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression.
Stahl S; Zivkov M; Reimitz PE; Panagides J; Hoff W
Acta Psychiatr Scand Suppl; 1997; 391():22-30. PubMed ID: 9265948
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine: clinical advantages in the treatment of depression.
Burrows GD; Kremer CM
J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():34S-39S. PubMed ID: 9090576
[TBL] [Abstract][Full Text] [Related]
8. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
CNS Drugs; 2010 Jan; 24(1):35-53. PubMed ID: 20030418
[TBL] [Abstract][Full Text] [Related]
9. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
10. Safety of mirtazapine in overdose.
Bremner JD; Wingard P; Walshe TA
J Clin Psychiatry; 1998 May; 59(5):233-5. PubMed ID: 9632033
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.
Tallon D; Wiles N; Campbell J; Chew-Graham C; Dickens C; Macleod U; Peters TJ; Lewis G; Anderson IM; Gilbody S; Hollingworth W; Davies S; Kessler D
Trials; 2016 Feb; 17():66. PubMed ID: 26842107
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
Smith WT; Glaudin V; Panagides J; Gilvary E
Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
[TBL] [Abstract][Full Text] [Related]
14. Mirtazapine: a review of its use in major depression.
Holm KJ; Markham A
Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
[TBL] [Abstract][Full Text] [Related]
15. Tolerability and patient compliance.
Roose SP
J Clin Psychiatry; 1999; 60 Suppl 17():14-7; discussion 46-8. PubMed ID: 10446736
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects.
Sennef C; Timmer CJ; Sitsen JM
Hum Psychopharmacol; 2003 Mar; 18(2):91-101. PubMed ID: 12590402
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Bremner JD
J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
[TBL] [Abstract][Full Text] [Related]
19. A review of the pharmacological and clinical profile of mirtazapine.
Anttila SA; Leinonen EV
CNS Drug Rev; 2001; 7(3):249-64. PubMed ID: 11607047
[TBL] [Abstract][Full Text] [Related]
20. Safety in overdose of mirtazapine: a case report.
Gerritsen AW
J Clin Psychiatry; 1997 Jun; 58(6):271. PubMed ID: 9228894
[No Abstract] [Full Text] [Related]
[Next] [New Search]